Cytokine-Induced Killer Cells
"Cytokine-Induced Killer Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mononuclear leukocytes that have been expanded in CELL CULTURE and activated with CYTOKINES such as INTERLEUKIN-2 to produce large numbers of highly cytotoxic cells.
| Descriptor ID |
D055612
|
| MeSH Number(s) |
A11.118.637.555.283 A11.251.476 A15.145.229.637.555.283 A15.382.490.555.283
|
| Concept/Terms |
Cytokine-Induced Killer Cells- Cytokine-Induced Killer Cells
- Cytokine Induced Killer Cells
- Cytokine-Induced Killer Cell
- Killer Cell, Cytokine-Induced
- Killer Cells, Cytokine-Induced
- CIK Cells
- CIK Cell
Lymphocyte-Activated Killer Cells- Lymphocyte-Activated Killer Cells
- Cell, Lymphocyte-Activated Killer
- Cells, Lymphocyte-Activated Killer
- Killer Cell, Lymphocyte-Activated
- Killer Cells, Lymphocyte-Activated
- Lymphocyte Activated Killer Cells
- Lymphocyte-Activated Killer Cell
- Lymphocyte Activated Killer Cell
|
Below are MeSH descriptors whose meaning is more general than "Cytokine-Induced Killer Cells".
Below are MeSH descriptors whose meaning is more specific than "Cytokine-Induced Killer Cells".
This graph shows the total number of publications written about "Cytokine-Induced Killer Cells" by people in this website by year, and whether "Cytokine-Induced Killer Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Cytokine-Induced Killer Cells" by people in Profiles.
-
The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials. J Immunol Res. 2018; 2018:9081938.
-
Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors. Cytotherapy. 2018 08; 20(8):1077-1088.
-
Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials. Int Immunopharmacol. 2018 Aug; 61:363-375.
-
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia. Hum Gene Ther. 2018 05; 29(5):602-613.
-
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells. Mol Med. 2017 10; 23:235-246.
-
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017 Dec; 23(12):2070-2078.
-
Continuous DC-CIK infusions restore CD8+ cellular immunity, physical activity and improve clinical efficacy in advanced cancer patients unresponsive to conventional treatments. Asian Pac J Cancer Prev. 2015; 16(6):2419-23.